Product NDC: | 63323-469 |
Proprietary Name: | Haloperidol Decanoate |
Non Proprietary Name: | HALOPERIDOL DECANOATE |
Active Ingredient(s): | 50 mg/mL & nbsp; HALOPERIDOL DECANOATE |
Administration Route(s): | INTRAMUSCULAR |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-469 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074893 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000216 |
Package NDC: | 63323-469-05 |
Package Description: | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-469-05) > 5 mL in 1 VIAL, MULTI-DOSE |
NDC Code | 63323-469-05 |
Proprietary Name | Haloperidol Decanoate |
Package Description | 1 VIAL, MULTI-DOSE in 1 CARTON (63323-469-05) > 5 mL in 1 VIAL, MULTI-DOSE |
Product NDC | 63323-469 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | HALOPERIDOL DECANOATE |
Dosage Form Name | INJECTION |
Route Name | INTRAMUSCULAR |
Start Marketing Date | 20000216 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | HALOPERIDOL DECANOATE |
Strength Number | 50 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Typical Antipsychotic [EPC] |